Akshikar is the Vice President & Managing Director of GSK (GlaxoSmithKline Pharmaceuticals Ltd) India
The Organisation of Pharmaceutical Producers of India (OPPI) has appointed Bhushan Akshikar as its President for a term of two years.
Akshikar is a seasoned business leader and has an experience of over 13 years in key leadership roles in GSK across India, the Middle East, Russia CIS & Africa region. Before joining GSK, Bhushan spent 15 years with Janssen, Johnson & Johnson, in local and regional positions in India, South Korea and Belgium.
Akshikar said, “I am excited and humbled to lead OPPI’s vision to collaborate with the Government of India to enhance access with innovation for patients, at such a crucial time for healthcare in our country. Over the years, OPPI’s focus has been on collective action to forge a path towards a more inclusive, innovative, and sustainable healthcare future for our country. I also extend my gratitude to the members of OPPI’s Executive Committee and I look forward to their continued support.”
Welcoming Akshikar as the President, Suresh Pattathil said “It has been my honour to serve as President of OPPI for the past two years, driving forth its vision of ‘Bharat Ke Liye’. As I transition from this role, I am pleased to hand over the leadership to my esteemed colleague, Bhushan Akshikar. I am confident that Bhushan will expertly guide OPPI towards new achievements by leveraging his valuable insights and experience, steering the organisation in the right direction to enable innovation, research, access and collaborations. I extend my best wishes to him and sincerely hope to witness OPPI reach new heights of success under his leadership.”
Anil Matai, Director General, OPPI said, “I would like to extend my heartfelt gratitude to Suresh for his steadfast dedication to advancing OPPI’s vision of enabling a healthier India through innovative solutions. We look forward to his continued guidance. I am thrilled to welcome Akshikar to his new role. His extensive experience and thought leadership in the pharmaceutical industry will be invaluable as OPPI continues to support the nation’s healthcare objectives with a patient-centric approach. Akshikar has consistently been a strong advocate for healthcare transformation in our country. Under his leadership, we are confident to enhance our efforts to optimise patient outcomes by fostering an environment that encourages innovation and growth."
